Drugs / DP-QB-MYA-002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07429162 | Jul 2026 → Jul 2027 expected | pulmonary non-tuberculous mycobacterial infection | Alberta Health services | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DP-QB-MYA-002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07429162 ↗ |
| Modality | Other / unclassified | “mycobacteriophage therapy” NCT07429162 ↗ |